---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-07-07T00:48:02.223497'
end_time: '2026-07-07T01:17:09.873929'
duration_seconds: 1747.65
template_file: templates/module_research.md.j2
template_variables:
  module_title: Terpenoid backbone biosynthesis
  module_summary: A bacterial terpenoid-backbone biosynthesis module centered on the
    methylerythritol phosphate (MEP/DOXP) pathway from pyruvate and glyceraldehyde
    3-phosphate to isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP),
    followed by prenyl-diphosphate synthases that extend these C5 units into geranyl,
    farnesyl, octaprenyl, and undecaprenyl diphosphates. In Pseudomonas putida KT2440,
    KEGG ppu00900 also pulls in thiolase/mevalonate-route-like entries and UbiX flavin
    prenyltransferase chemistry; those are treated as boundary or downstream uses
    rather than evidence for a strict mevalonate pathway.
  module_outline: "- Terpenoid backbone biosynthesis\n  - 1. DXP formation\n  - 1-deoxy-D-xylulose\
    \ 5-phosphate formation\n    - Dxs 1-deoxy-D-xylulose-5-phosphate synthase (molecular\
    \ player: PSEPK dxs; activity or role: 1-deoxy-D-xylulose-5-phosphate synthase\
    \ activity)\n  - 2. MEP formation\n  - DXP reductoisomerization\n    - Dxr 1-deoxy-D-xylulose-5-phosphate\
    \ reductoisomerase (molecular player: PSEPK dxr; activity or role: 1-deoxy-D-xylulose-5-phosphate\
    \ reductoisomerase activity)\n  - 3. CDP-ME formation\n  - MEP cytidylyltransferase\
    \ step\n    - IspD MEP cytidylyltransferase (molecular player: PSEPK ispD; activity\
    \ or role: 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity)\n\
    \  - 4. CDP-ME phosphorylation\n  - CDP-ME kinase step\n    - IspE CDP-ME kinase\
    \ (molecular player: PSEPK ispE; activity or role: 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol\
    \ kinase activity)\n  - 5. MEcPP formation\n  - MEcPP synthase step\n    - IspF\
    \ MEcPP synthase (molecular player: PSEPK ispF; activity or role: 2-C-methyl-D-erythritol\
    \ 2,4-cyclodiphosphate synthase activity)\n  - 6. HMBPP formation\n  - HMBPP synthase\
    \ step\n    - IspG HMBPP synthase (molecular player: PSEPK ispG; activity or role:\
    \ 4-hydroxy-3-methylbut-2-enyl-diphosphate synthase activity (flavodoxin))\n \
    \ - 7. IPP and DMAPP formation\n  - HMBPP reductase step\n    - IspH HMBPP reductase\
    \ (molecular player: PSEPK ispH; activity or role: 4-hydroxy-3-methylbut-2-enyl\
    \ diphosphate reductase activity)\n  - 8. short-chain prenyl diphosphate synthesis\n\
    \  - Farnesyl diphosphate synthesis\n    - IspA farnesyl diphosphate synthase\
    \ (molecular player: PSEPK ispA; activity or role: (2E,6E)-farnesyl diphosphate\
    \ synthase activity)\n  - 9. ubiquinone-side-chain precursor synthesis\n  - Octaprenyl\
    \ diphosphate synthesis\n    - IspB octaprenyl diphosphate synthase (molecular\
    \ player: PSEPK ispB; activity or role: all-trans-octaprenyl-diphosphate synthase\
    \ activity)\n  - 10. undecaprenyl carrier-lipid precursor synthesis\n  - Undecaprenyl\
    \ diphosphate synthesis\n    - UppS undecaprenyl diphosphate synthase (molecular\
    \ player: PSEPK uppS; activity or role: ditrans,polycis-undecaprenyl-diphosphate\
    \ synthase [(2E,6E)-farnesyl-diphosphate specific] activity)"
  module_connections: No explicit connections.
provider_config:
  timeout: null
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
    max_embedded_images: 8
citation_count: 38
artifact_count: 2
artifact_sources:
  edison_answer_artifacts: 2
artifacts:
- filename: artifact-00.md
  path: terpenoid_backbone_biosynthesis-deep-research-falcon_artifacts/artifact-00.md
  media_type: text/markdown
  source: edison_answer_artifacts
  data_storage_id: null
  description: Edison artifact artifact-00
- filename: artifact-01.md
  path: terpenoid_backbone_biosynthesis-deep-research-falcon_artifacts/artifact-01.md
  media_type: text/markdown
  source: edison_answer_artifacts
  data_storage_id: null
  description: Edison artifact artifact-01
---

## Question

# Commissioned Review Brief

## Review Topic

Terpenoid backbone biosynthesis

## Working Scope

A bacterial terpenoid-backbone biosynthesis module centered on the methylerythritol phosphate (MEP/DOXP) pathway from pyruvate and glyceraldehyde 3-phosphate to isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), followed by prenyl-diphosphate synthases that extend these C5 units into geranyl, farnesyl, octaprenyl, and undecaprenyl diphosphates. In Pseudomonas putida KT2440, KEGG ppu00900 also pulls in thiolase/mevalonate-route-like entries and UbiX flavin prenyltransferase chemistry; those are treated as boundary or downstream uses rather than evidence for a strict mevalonate pathway.

## Provisional Biological Outline

- Terpenoid backbone biosynthesis
  - 1. DXP formation
  - 1-deoxy-D-xylulose 5-phosphate formation
    - Dxs 1-deoxy-D-xylulose-5-phosphate synthase (molecular player: PSEPK dxs; activity or role: 1-deoxy-D-xylulose-5-phosphate synthase activity)
  - 2. MEP formation
  - DXP reductoisomerization
    - Dxr 1-deoxy-D-xylulose-5-phosphate reductoisomerase (molecular player: PSEPK dxr; activity or role: 1-deoxy-D-xylulose-5-phosphate reductoisomerase activity)
  - 3. CDP-ME formation
  - MEP cytidylyltransferase step
    - IspD MEP cytidylyltransferase (molecular player: PSEPK ispD; activity or role: 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity)
  - 4. CDP-ME phosphorylation
  - CDP-ME kinase step
    - IspE CDP-ME kinase (molecular player: PSEPK ispE; activity or role: 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase activity)
  - 5. MEcPP formation
  - MEcPP synthase step
    - IspF MEcPP synthase (molecular player: PSEPK ispF; activity or role: 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity)
  - 6. HMBPP formation
  - HMBPP synthase step
    - IspG HMBPP synthase (molecular player: PSEPK ispG; activity or role: 4-hydroxy-3-methylbut-2-enyl-diphosphate synthase activity (flavodoxin))
  - 7. IPP and DMAPP formation
  - HMBPP reductase step
    - IspH HMBPP reductase (molecular player: PSEPK ispH; activity or role: 4-hydroxy-3-methylbut-2-enyl diphosphate reductase activity)
  - 8. short-chain prenyl diphosphate synthesis
  - Farnesyl diphosphate synthesis
    - IspA farnesyl diphosphate synthase (molecular player: PSEPK ispA; activity or role: (2E,6E)-farnesyl diphosphate synthase activity)
  - 9. ubiquinone-side-chain precursor synthesis
  - Octaprenyl diphosphate synthesis
    - IspB octaprenyl diphosphate synthase (molecular player: PSEPK ispB; activity or role: all-trans-octaprenyl-diphosphate synthase activity)
  - 10. undecaprenyl carrier-lipid precursor synthesis
  - Undecaprenyl diphosphate synthesis
    - UppS undecaprenyl diphosphate synthase (molecular player: PSEPK uppS; activity or role: ditrans,polycis-undecaprenyl-diphosphate synthase [(2E,6E)-farnesyl-diphosphate specific] activity)

## Known Relationships Among Steps

No explicit connections.

## Assignment

Write a rigorous, review-style synthesis suitable for a molecular biology
audience. Treat the topic as a biological system whose boundaries, core
mechanisms, variants, and unresolved points should be made clear to readers who
know the field but are not specialists in this specific process.

The review should be explanatory rather than encyclopedic. Anchor broad claims
in primary literature or authoritative reviews, but keep the focus on how the
system works and how its parts fit together.

## Questions To Address

1. **Scope and boundaries**
   - What exactly is included in this biological system?
   - Which neighboring pathways, organelle processes, complexes, or regulatory
     events are often confused with it but should be treated separately?
   - Are there competing definitions in the literature?

2. **Core mechanism**
   - What is the best current model for the sequence of events?
   - Which steps are obligatory, which are conditional, and which are accessory?
   - What molecular assemblies, enzymes, receptors, adaptors, transporters, or
     structural units carry out each major step?

3. **Variation**
   - How does the system vary across major evolutionary lineages?
   - Are there well-supported differences between cell types, tissues,
     developmental stages, physiological states, or compartments?
   - Where are there alternative routes that achieve a similar outcome by
     different molecular means?

4. **Conservation and origin**
   - What is the deepest plausible evolutionary origin of the system?
   - Which parts appear ancient and conserved, and which appear to be later
     elaborations, replacements, or lineage-specific losses?
   - When a protein family has expanded, which family members are the best
     representatives for understanding the ancestral role?

5. **Physical and biological constraints**
   - What steps must occur in a particular order?
   - Which events are mutually exclusive, compartment-specific, cell-type
     specific, substrate-specific, or stage-specific?
   - What evidence rules out otherwise plausible paths through the system?

6. **Evidence and controversy**
   - Which mechanistic claims are strongly supported by experiments?
   - Where does the literature disagree, rely on indirect evidence, or mix data
     from organisms that may not be comparable?
   - What are the most important open questions?

## Output Format

Use the style and structure of a concise review article:

1. Executive summary
2. Definition and biological boundaries
3. Mechanistic overview
4. Major molecular players and active assemblies
5. Evolutionary and cell-biological variation
6. Constraints, dependencies, and failure modes
7. Controversies and open questions
8. Key references

Include citations for major claims, preferably PMIDs or DOIs. Be explicit about
uncertainty and avoid overgeneralizing from one organism, cell type, or assay
system to all biology.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Commissioned Review Brief

## Review Topic

Terpenoid backbone biosynthesis

## Working Scope

A bacterial terpenoid-backbone biosynthesis module centered on the methylerythritol phosphate (MEP/DOXP) pathway from pyruvate and glyceraldehyde 3-phosphate to isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), followed by prenyl-diphosphate synthases that extend these C5 units into geranyl, farnesyl, octaprenyl, and undecaprenyl diphosphates. In Pseudomonas putida KT2440, KEGG ppu00900 also pulls in thiolase/mevalonate-route-like entries and UbiX flavin prenyltransferase chemistry; those are treated as boundary or downstream uses rather than evidence for a strict mevalonate pathway.

## Provisional Biological Outline

- Terpenoid backbone biosynthesis
  - 1. DXP formation
  - 1-deoxy-D-xylulose 5-phosphate formation
    - Dxs 1-deoxy-D-xylulose-5-phosphate synthase (molecular player: PSEPK dxs; activity or role: 1-deoxy-D-xylulose-5-phosphate synthase activity)
  - 2. MEP formation
  - DXP reductoisomerization
    - Dxr 1-deoxy-D-xylulose-5-phosphate reductoisomerase (molecular player: PSEPK dxr; activity or role: 1-deoxy-D-xylulose-5-phosphate reductoisomerase activity)
  - 3. CDP-ME formation
  - MEP cytidylyltransferase step
    - IspD MEP cytidylyltransferase (molecular player: PSEPK ispD; activity or role: 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity)
  - 4. CDP-ME phosphorylation
  - CDP-ME kinase step
    - IspE CDP-ME kinase (molecular player: PSEPK ispE; activity or role: 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase activity)
  - 5. MEcPP formation
  - MEcPP synthase step
    - IspF MEcPP synthase (molecular player: PSEPK ispF; activity or role: 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity)
  - 6. HMBPP formation
  - HMBPP synthase step
    - IspG HMBPP synthase (molecular player: PSEPK ispG; activity or role: 4-hydroxy-3-methylbut-2-enyl-diphosphate synthase activity (flavodoxin))
  - 7. IPP and DMAPP formation
  - HMBPP reductase step
    - IspH HMBPP reductase (molecular player: PSEPK ispH; activity or role: 4-hydroxy-3-methylbut-2-enyl diphosphate reductase activity)
  - 8. short-chain prenyl diphosphate synthesis
  - Farnesyl diphosphate synthesis
    - IspA farnesyl diphosphate synthase (molecular player: PSEPK ispA; activity or role: (2E,6E)-farnesyl diphosphate synthase activity)
  - 9. ubiquinone-side-chain precursor synthesis
  - Octaprenyl diphosphate synthesis
    - IspB octaprenyl diphosphate synthase (molecular player: PSEPK ispB; activity or role: all-trans-octaprenyl-diphosphate synthase activity)
  - 10. undecaprenyl carrier-lipid precursor synthesis
  - Undecaprenyl diphosphate synthesis
    - UppS undecaprenyl diphosphate synthase (molecular player: PSEPK uppS; activity or role: ditrans,polycis-undecaprenyl-diphosphate synthase [(2E,6E)-farnesyl-diphosphate specific] activity)

## Known Relationships Among Steps

No explicit connections.

## Assignment

Write a rigorous, review-style synthesis suitable for a molecular biology
audience. Treat the topic as a biological system whose boundaries, core
mechanisms, variants, and unresolved points should be made clear to readers who
know the field but are not specialists in this specific process.

The review should be explanatory rather than encyclopedic. Anchor broad claims
in primary literature or authoritative reviews, but keep the focus on how the
system works and how its parts fit together.

## Questions To Address

1. **Scope and boundaries**
   - What exactly is included in this biological system?
   - Which neighboring pathways, organelle processes, complexes, or regulatory
     events are often confused with it but should be treated separately?
   - Are there competing definitions in the literature?

2. **Core mechanism**
   - What is the best current model for the sequence of events?
   - Which steps are obligatory, which are conditional, and which are accessory?
   - What molecular assemblies, enzymes, receptors, adaptors, transporters, or
     structural units carry out each major step?

3. **Variation**
   - How does the system vary across major evolutionary lineages?
   - Are there well-supported differences between cell types, tissues,
     developmental stages, physiological states, or compartments?
   - Where are there alternative routes that achieve a similar outcome by
     different molecular means?

4. **Conservation and origin**
   - What is the deepest plausible evolutionary origin of the system?
   - Which parts appear ancient and conserved, and which appear to be later
     elaborations, replacements, or lineage-specific losses?
   - When a protein family has expanded, which family members are the best
     representatives for understanding the ancestral role?

5. **Physical and biological constraints**
   - What steps must occur in a particular order?
   - Which events are mutually exclusive, compartment-specific, cell-type
     specific, substrate-specific, or stage-specific?
   - What evidence rules out otherwise plausible paths through the system?

6. **Evidence and controversy**
   - Which mechanistic claims are strongly supported by experiments?
   - Where does the literature disagree, rely on indirect evidence, or mix data
     from organisms that may not be comparable?
   - What are the most important open questions?

## Output Format

Use the style and structure of a concise review article:

1. Executive summary
2. Definition and biological boundaries
3. Mechanistic overview
4. Major molecular players and active assemblies
5. Evolutionary and cell-biological variation
6. Constraints, dependencies, and failure modes
7. Controversies and open questions
8. Key references

Include citations for major claims, preferably PMIDs or DOIs. Be explicit about
uncertainty and avoid overgeneralizing from one organism, cell type, or assay
system to all biology.

# Terpenoid Backbone Biosynthesis in Bacteria: The MEP/DOXP Pathway Module

## 1. Executive Summary

Terpenoid backbone biosynthesis in bacteria centers on the methylerythritol phosphate (MEP) pathway, also known as the DOXP pathway, which converts pyruvate and glyceraldehyde 3-phosphate (G3P) into the universal C5 isoprenoid precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) (allamand2023themultifacetedmep pages 1-3, rinaldi2022alternativemetabolicpathways pages 4-4). In organisms such as *Pseudomonas putida* KT2440, this seven-enzyme core pathway is extended by prenyl diphosphate synthases—IspA (farnesyl diphosphate synthase), IspB (octaprenyl diphosphate synthase), and UppS (undecaprenyl diphosphate synthase)—that elongate C5 building blocks into C15, C40, and C55 prenyl chains required for diverse downstream products including ubiquinone, menaquinone, peptidoglycan carrier lipids, and carotenoids (kay2024engineeringescherichiacoli pages 2-4, kay2024engineeringescherichiacoli pages 1-2). The MEP pathway is the dominant isoprenoid biosynthetic route in bacteria and plastids, while the mevalonate (MVA) pathway fulfills this role in archaea and most eukaryotes (perezgil2024themethylerythritolphosphate pages 7-8, garay2026themevalonatepathway pages 16-18, perezgil2024themethylerythritolphosphate pages 1-3). Recent work has revealed that the MEP pathway serves not only as a biosynthetic conduit but also as an oxidative stress sense-and-response system, mediated by the oxygen sensitivity of its terminal iron-sulfur (Fe-S) cluster enzymes IspG and IspH (perezgil2024themethylerythritolphosphate pages 4-4, perezgil2024themethylerythritolphosphate pages 7-8, perezgil2024themethylerythritolphosphate pages 1-3). Comparative genomics across 4,400 bacterial species has demonstrated that while the first enzyme Dxs shows evolutionary flexibility with natural alternatives, IspG and IspH are evolutionarily indispensable with no known bypasses (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 9-10, marshall2023evolutionaryflexibilityand pages 1-2).

## 2. Definition and Biological Boundaries

### 2.1 What is included

The terpenoid backbone biosynthesis module, as defined here with reference to the KEGG annotation ppu00900 in *P. putida* KT2440, encompasses ten enzymatic steps organized into two functional tiers:

**Tier 1 – The core MEP pathway (Steps 1–7):** Seven sequential enzymatic transformations converting pyruvate + G3P → DXP → MEP → CDP-ME → CDP-ME2P → MEcPP → HMBPP → IPP + DMAPP. Each step is catalyzed by a dedicated enzyme (Dxs, Dxr, IspD, IspE, IspF, IspG, IspH) (allamand2023themultifacetedmep pages 1-3, rinaldi2022alternativemetabolicpathways pages 4-4).

**Tier 2 – Prenyl diphosphate extension (Steps 8–10):** Three prenyltransferases that extend IPP/DMAPP into longer chain prenyl diphosphates: IspA generates farnesyl diphosphate (FPP, C15), IspB generates octaprenyl diphosphate (OPP, C40) for ubiquinone side chains, and UppS generates undecaprenyl diphosphate (Und-PP, C55) as the precursor for the bactoprenyl lipid carrier essential for peptidoglycan and surface glycan assembly (kay2024engineeringescherichiacoli pages 2-4, kay2024engineeringescherichiacoli pages 1-2).

The complete pathway summary is presented in the following table:

| Step | Step name | Enzyme name (common; gene) | *P. putida* KT2440 designation | EC number | Substrate(s) | Product(s) | Cofactors / requirements | Key features | Evolutionary status |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DXP formation | 1-Deoxy-D-xylulose-5-phosphate synthase; **dxs** | PSEPK_dxs | **2.2.1.7** | Pyruvate + D-glyceraldehyde 3-phosphate | 1-Deoxy-D-xylulose 5-phosphate (DXP) + CO2 | ThDP/TPP, Mg2+ | First committed MEP-pathway step; often major flux-control/rate-limiting node; DXP also feeds thiamine (B1) and pyridoxal/pyridoxine (B6) biosynthesis; candidate target for engineering and inhibition (rinaldi2022alternativemetabolicpathways pages 4-4, hamid2024investigatingstructuralinsights pages 26-31, hamid2024investigatingstructuralinsights pages 23-26) | **Flexible**; only MEP enzyme with evidence for natural alternatives/bypasses in some bacteria (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 9-10, marshall2023evolutionaryflexibilityand pages 3-5, marshall2023evolutionaryflexibilityand pages 1-2) |
| 2 | MEP formation | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase; **dxr/ispC** | PSEPK_dxr | **1.1.1.267** | DXP + NADPH | 2-C-Methyl-D-erythritol 4-phosphate (MEP) + NADP+ | NADPH, divalent metal (commonly Mg2+ or Mn2+) | Performs reductoisomerization from DXP to MEP; canonical early committed step after DXS; major antibacterial drug target classically inhibited by fosmidomycin analogs in many organisms (allamand2023themultifacetedmep pages 1-3, rinaldi2022alternativemetabolicpathways pages 4-4) | **Rigid**; Marshall et al. found no convincing alternatives to DxrI/II in MEP-utilizing bacteria (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 9-10, marshall2023evolutionaryflexibilityand pages 5-7) |
| 3 | CDP-ME formation | MEP cytidylyltransferase; **ispD** | PSEPK_ispD | **2.7.7.60** | MEP + CTP | 4-Diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) + PPi | CTP; Mg2+ typically required | Activates MEP by cytidylyl transfer; in some bacteria may occur in proximity to IspE/IspF or as part of bifunctional arrangements, but chemistry remains obligatory (allamand2023themultifacetedmep pages 1-3, khana2023systematicanalysisof pages 2-4, rinaldi2022alternativemetabolicpathways pages 4-4) | **Rigid**; no established alternative enzymes/pathways identified (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 9-10) |
| 4 | CDP-ME phosphorylation | CDP-ME kinase; **ispE** | PSEPK_ispE | **2.7.1.148** | CDP-ME + ATP | CDP-ME2P [4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol 2-phosphate] + ADP | ATP, Mg2+ | ATP-dependent phosphorylation step; chemically obligatory in the canonical bacterial MEP pathway (allamand2023themultifacetedmep pages 1-3, khana2023systematicanalysisof pages 2-4) | **Rigid**; no validated bypasses known (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 9-10) |
| 5 | MEcPP formation | MEcPP synthase; **ispF** | PSEPK_ispF | **4.6.1.12** | CDP-ME2P | 2-C-Methyl-D-erythritol 2,4-cyclodiphosphate (MEcPP) + CMP | Usually Zn2+ in active site / divalent-metal-assisted catalysis | Generates the unusual cyclic diphosphate intermediate MEcPP; MEcPP is a major branchpoint metabolite in stress physiology and accumulates when downstream IspG flux is impaired (allamand2023themultifacetedmep pages 1-3, perezgil2024themethylerythritolphosphate pages 4-4, perezgil2024themethylerythritolphosphate pages 1-3, perezgil2024themethylerythritolphosphate pages 6-7) | **Rigid**; no established alternatives identified (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 9-10) |
| 6 | HMBPP formation | HMBPP synthase (GcpE); **ispG** | PSEPK_ispG | **1.17.7.1** | MEcPP + reducing equivalents | (E)-4-Hydroxy-3-methylbut-2-enyl diphosphate (HMBPP) | **4Fe-4S** cluster; electrons from flavodoxin/flavodoxin reductase or related redox partners | Penultimate MEP enzyme; oxygen/redox sensitive; major bottleneck under engineering conditions; reduced IspG activity causes **MEcPP accumulation** and links pathway behavior to oxidative-stress sensing/response (khana2023systematicanalysisof pages 2-4, perezgil2024themethylerythritolphosphate pages 4-4, perezgil2024themethylerythritolphosphate pages 7-8, perezgil2024themethylerythritolphosphate pages 1-3, perezgil2024themethylerythritolphosphate pages 4-6, perezgil2024themethylerythritolphosphate pages 6-7) | **Rigid**; no alternative route known, appears evolutionarily indispensable (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 5-7, marshall2023evolutionaryflexibilityand pages 1-2) |
| 7 | IPP and DMAPP formation | HMBPP reductase (LytB); **ispH** | PSEPK_ispH | **1.17.7.4** | HMBPP + reducing equivalents | IPP + DMAPP (often ~5:1 IPP:DMAPP) | **4Fe-4S** cluster; reduced ferredoxin/flavodoxin-type electron supply | Final MEP step; oxygen-sensitive Fe-S enzyme; often rate-limiting with IspG; controls terminal flux and product ratio into C5 building blocks; central to stress-linked pathway regulation (rinaldi2022alternativemetabolicpathways pages 4-4, perezgil2024themethylerythritolphosphate pages 4-4, perezgil2024themethylerythritolphosphate pages 8-9, perezgil2024themethylerythritolphosphate pages 7-8, perezgil2024themethylerythritolphosphate pages 1-3) | **Rigid**; no bypasses identified across surveyed bacteria (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 5-7, marshall2023evolutionaryflexibilityand pages 1-2) |
| 8 | Short-chain prenyl diphosphate synthesis | Farnesyl diphosphate synthase; **ispA** | PSEPK_ispA | **2.5.1.10** | DMAPP + IPP + IPP (via GPP intermediate) | Geranyl diphosphate (GPP) then **farnesyl diphosphate (FPP)** | Mg2+ or Mn2+ | Head-to-tail trans-prenyltransferase supplying the C15 branchpoint precursor; FPP feeds many terpenoids and also serves as substrate input for longer-chain synthases such as UppS and, in some systems, polyprenyl synthases (scope boundary: elongation after IPP/DMAPP, not core MEP chemistry) (rinaldi2022alternativemetabolicpathways pages 4-4, kay2024engineeringescherichiacoli pages 2-4) | **Not assessed in Marshall 2023** (outside core MEP-flexibility analysis) |
| 9 | Ubiquinone-side-chain precursor synthesis | Octaprenyl diphosphate synthase; **ispB** | PSEPK_ispB | **2.5.1.90** | FPP + 5 IPP | all-trans-Octaprenyl diphosphate (OPP) | Mg2+ / Mn2+ | Long-chain trans-prenyltransferase providing the isoprenoid side chain for **ubiquinone/CoQ** biosynthesis in many bacteria; competes with UppS for prenyl precursors; altering IspB can redirect flux among quinone and carrier-lipid branches (kay2024engineeringescherichiacoli pages 2-4, kay2024engineeringescherichiacoli pages 1-2, bao2021adynamicand pages 3-4) | **Not assessed in Marshall 2023** |
| 10 | Undecaprenyl carrier-lipid precursor synthesis | Undecaprenyl diphosphate synthase; **uppS** | PSEPK_uppS | **2.5.1.31** | FPP + 8 IPP | Undecaprenyl diphosphate (Und-PP) | Mg2+ / Mn2+; membrane-associated downstream dephosphorylation to Und-P by BacA/PAP2 phosphatases | Produces the C55 bactoprenyl carrier precursor required for peptidoglycan and many surface glycans; **competes with IspB for IPP/FPP**; uppS overexpression can strongly increase Und-P availability and glycan output (3-fold higher Und-P than WT in engineered *E. coli* background) (kay2024engineeringescherichiacoli pages 2-4, kay2024engineeringescherichiacoli pages 1-2) | **Not assessed in Marshall 2023** |


*Table: This table summarizes the core bacterial MEP/DOXP pathway and its immediate prenyl-diphosphate extension steps in the requested 10-step module, including enzyme chemistry, likely *Pseudomonas putida* KT2440 gene designations, cofactors, and evolutionary status where available. It is useful as a compact reference linking pathway order, biochemical function, and current evidence on bottlenecks and conservation.*

### 2.2 What is excluded (boundary conditions)

Several neighboring pathways and processes are frequently confused with the terpenoid backbone module but should be treated as distinct:

- **The mevalonate (MVA) pathway.** Although KEGG ppu00900 for *P. putida* KT2440 pulls in thiolase/mevalonate-route-like entries, these are best treated as boundary annotations rather than evidence for a functional MVA pathway in this organism. The vast majority of Pseudomonadota rely exclusively on the MEP pathway (perezgil2024themethylerythritolphosphate pages 7-8, perezgil2024themethylerythritolphosphate pages 1-3).

- **Downstream terpenoid decoration.** Terpene synthases and cyclases (e.g., carotenoid synthases, hopanoid cyclases), ubiquinone ring modification enzymes (UbiA, UbiX prenyltransferase chemistry), and menaquinone-specific biosynthetic steps lie downstream of the backbone module. UbiX flavin prenyltransferase uses DMAPP but is a consumer of the backbone rather than part of it.

- **DXP-branching to thiamine and pyridoxal.** The DXP intermediate produced by Dxs also feeds into thiamine (vitamin B1) and pyridoxine (vitamin B6) biosynthesis, making Dxs a metabolic node shared between isoprenoid and vitamin pathways (hamid2024investigatingstructuralinsights pages 26-31, hamid2024investigatingstructuralinsights pages 23-26). These vitamin branches are not part of terpenoid backbone biosynthesis per se.

- **IPP isomerase (IDI/Idi).** In organisms relying exclusively on the MEP pathway, IDI is not essential because IspH directly produces both IPP and DMAPP (at an approximate 5:1 ratio) (rinaldi2022alternativemetabolicpathways pages 4-4). IDI is therefore accessory rather than obligatory in this context.

## 3. Mechanistic Overview

### 3.1 The core MEP pathway: a seven-step linear sequence

The MEP pathway operates as a largely linear, obligatory sequence. Each step must occur in order because substrates for downstream reactions are the products of upstream ones (allamand2023themultifacetedmep pages 1-3, khana2023systematicanalysisof pages 2-4, rinaldi2022alternativemetabolicpathways pages 4-4).

**Step 1 (DXP formation):** Dxs catalyzes the thiamine diphosphate (ThDP)-dependent condensation of pyruvate and G3P to form 1-deoxy-D-xylulose 5-phosphate (DXP) with release of CO2. Dxs exhibits the highest flux-control coefficient among MEP pathway enzymes and is widely regarded as the primary rate-limiting step (hamid2024investigatingstructuralinsights pages 23-26, rinaldi2022alternativemetabolicpathways pages 4-4).

**Step 2 (MEP formation):** Dxr (IspC) performs an NADPH-dependent reductoisomerization of DXP to 2-C-methyl-D-erythritol 4-phosphate (MEP). This is the first step unique to isoprenoid biosynthesis (DXP also feeds vitamin pathways) and is the validated target of the antibiotic fosmidomycin (allamand2023themultifacetedmep pages 1-3, rinaldi2022alternativemetabolicpathways pages 4-4).

**Steps 3–5 (Cytidylyl activation, phosphorylation, and cyclization):** IspD activates MEP with CTP to form CDP-ME; IspE phosphorylates CDP-ME using ATP to produce CDP-ME2P; IspF catalyzes intramolecular cyclization with loss of CMP to yield the unusual cyclic intermediate MEcPP (2-C-methyl-D-erythritol 2,4-cyclodiphosphate) (allamand2023themultifacetedmep pages 1-3, khana2023systematicanalysisof pages 2-4). In some bacteria, IspD and IspF occur as a bifunctional fusion protein (IspDF), as observed in *Zymomonas mobilis* (khana2023systematicanalysisof pages 2-4).

**Steps 6–7 (Reductive dephosphorylation via Fe-S enzymes):** IspG opens the cyclic diphosphate of MEcPP in a reductive dehydroxylation requiring a [4Fe-4S] cluster and electron supply from flavodoxin/ferredoxin to produce HMBPP. IspH then reduces HMBPP to yield IPP and DMAPP, also using a [4Fe-4S] cluster. The IspH-catalyzed reaction produces IPP and DMAPP at an approximate 5:1 ratio (rinaldi2022alternativemetabolicpathways pages 4-4, perezgil2024themethylerythritolphosphate pages 4-4, perezgil2024themethylerythritolphosphate pages 3-4). The overall MEP pathway consumes 3 NADPH and 3 ATP per molecule of IPP/DMAPP produced from pyruvate and G3P (rinaldi2022alternativemetabolicpathways pages 4-4).

### 3.2 Prenyl chain extension

**Step 8 (FPP synthesis):** IspA catalyzes sequential head-to-tail condensation of DMAPP + IPP → GPP (C10), then GPP + IPP → FPP (C15). FPP serves as the central C15 branchpoint precursor for sesquiterpenes, squalene-derived hopanoids, and as the starting substrate for longer-chain synthases (rinaldi2022alternativemetabolicpathways pages 4-4).

**Step 9 (OPP synthesis):** IspB extends FPP by five additional IPP units to generate all-trans-octaprenyl diphosphate (C40), which provides the isoprenoid side chain for ubiquinone (CoQ8) in *E. coli* and many Pseudomonadota. The chain length specificity of polyprenyl diphosphate synthases varies across bacteria; replacing IspB with decaprenyl diphosphate synthase (DdsA) shifts production toward CoQ10-length chains (kay2024engineeringescherichiacoli pages 2-4).

**Step 10 (Und-PP synthesis):** UppS adds eight IPP units to FPP in the *cis*-configuration to generate undecaprenyl diphosphate (C55), which is dephosphorylated by BacA/PAP2 phosphatases to yield undecaprenyl phosphate (Und-P), the essential lipid carrier for peptidoglycan, O-antigen, ECA, and other surface glycan biosynthesis. UppS and IspB compete for the same IPP and FPP substrate pools; under aerobic growth conditions in *E. coli*, Und-PP synthesis is limited by this competition, and overexpression of *uppS* can increase Und-P levels up to 3-fold (kay2024engineeringescherichiacoli pages 2-4, kay2024engineeringescherichiacoli pages 1-2).

### 3.3 Obligatory vs. conditional steps

All seven core MEP pathway steps (Dxs through IspH) are obligatory for IPP/DMAPP production in bacteria that rely solely on this route. Among the prenyl transferases, IspA is essential in nearly all bacteria because FPP is a universal precursor; IspB essentiality depends on whether the organism uses ubiquinone; UppS is essential in virtually all bacteria because Und-P is required for peptidoglycan biosynthesis (kay2024engineeringescherichiacoli pages 1-2). IDI (isopentenyl diphosphate isomerase), while useful for optimizing IPP:DMAPP ratios in engineered contexts, is not essential in MEP-only organisms (rinaldi2022alternativemetabolicpathways pages 4-4).

## 4. Major Molecular Players and Active Assemblies

The detailed properties of each enzyme are summarized in Table 1 above. Several features merit additional emphasis:

**Dxs as a metabolic hub.** DXP synthase sits at the intersection of isoprenoid, thiamine, and pyridoxal biosynthesis. It exhibits the highest flux-control coefficient in the MEP pathway and is a ThDP-dependent enzyme structurally related to transketolase (hamid2024investigatingstructuralinsights pages 26-31, hamid2024investigatingstructuralinsights pages 23-26). Overexpression of DXS in *Zymomonas mobilis* triggers large increases in intracellular levels of the first five MEP intermediates, with MEcPP accumulating most substantially—revealing IspG/IspH as downstream bottlenecks that become rate-limiting when DXS flux is elevated (khana2023systematicanalysisof pages 2-4).

**IspG and IspH: Fe-S cluster enzymes as redox sensors.** Both enzymes contain [4Fe-4S] clusters that are inherently sensitive to reactive oxygen species (ROS). Under oxidative stress, IspG activity decreases, causing MEcPP accumulation (perezgil2024themethylerythritolphosphate pages 4-4, perezgil2024themethylerythritolphosphate pages 7-8, perezgil2024themethylerythritolphosphate pages 4-6, perezgil2024themethylerythritolphosphate pages 6-7). Structural studies show that substrate binding to IspG induces conformational changes that close the active site and partially protect the Fe-S cluster from oxidative dissociation (perezgil2024themethylerythritolphosphate pages 4-6). IspH has evolved variant classes in aerobic vs. anaerobic bacteria with differential N- and C-terminal regions that modulate sensitivity to oxidation (perezgil2024themethylerythritolphosphate pages 8-9).

**UppS vs. IspB competition.** These two prenyltransferases compete for IPP and FPP (kay2024engineeringescherichiacoli pages 2-4). Engineering Und-P availability by overexpressing *uppS* in *E. coli* cells deleted for non-essential glycan-priming enzymes increased Und-P from ~123,000 to ~387,000 molecules per cell—a 215% increase—with dramatic improvements in recombinant glycan expression (kay2024engineeringescherichiacoli pages 2-4, kay2024engineeringescherichiacoli pages 1-2).

## 5. Evolutionary and Cell-Biological Variation

### 5.1 Distribution across domains

The distribution of the MEP and MVA pathways across the tree of life is summarized in the following table:

| Domain/Lineage | MEP pathway | MVA pathway type | Compartmentalization notes | Key examples | Notes on HGT or special cases |
|---|---|---|---|---|---|
| Most bacteria | Present in the majority of lineages | Usually absent | Cytosolic bacterial pathway; no organelle compartmentation in typical bacteria | *Escherichia coli*, many proteobacteria and cyanobacteria | Current evidence supports MEP as the dominant bacterial route and likely vertically inherited from a bacterial common ancestor; however, some bacterial clades also carry MVA variants, so “bacteria = MEP only” is an oversimplification (perezgil2024themethylerythritolphosphate pages 7-8, kanno2024archaealmevalonatepathway pages 1-3, perezgil2024themethylerythritolphosphate pages 1-3) |
| Archaea | Generally absent | Archaeal MVA pathway widely conserved; multiple archaeal modified variants exist | Cytosolic pathway in archaeal cells | Sulfolobales, Thermoplasmatales, Halobacteria | Archaeal MVA pathways occur in several forms and appear evolutionarily distinct from canonical bacterial MEP; Fe-S chemistry is retained in archaeal MVA evolution more than in eukaryotic MVA (perezgil2024themethylerythritolphosphate pages 7-8, kanno2024archaealmevalonatepathway pages 1-3, carruthers2021diversifyingisoprenoidplatforms pages 2-3) |
| Fungi | Absent | Eukaryotic MVA | Cytosol/endomembrane-associated eukaryotic pathway | *Saccharomyces cerevisiae* | Standard eukaryotic condition; no evidence that fungi retain a full MEP route (garay2026themevalonatepathway pages 16-18) |
| Animals | Absent | Eukaryotic MVA | Cytosol, ER, and associated eukaryotic compartments | Mammals, insects | Canonical eukaryotic state; animals rely on MVA rather than MEP for isoprenoid precursor production (garay2026themevalonatepathway pages 16-18) |
| Land plants and green algae | Present | Eukaryotic MVA also present | Dual, nonredundant compartmentation: MEP in plastids; MVA in cytosol/ER/peroxisome-associated compartments | *Arabidopsis thaliana*, crop plants, green algae | Plants are a major special case because both complete pathways coexist and are not fully interchangeable; plastidial MEP reflects bacterial endosymbiotic origin (perezgil2024themethylerythritolphosphate pages 7-8, garay2026themevalonatepathway pages 16-18, perezgil2024themethylerythritolphosphate pages 1-3) |
| Plastid-bearing eukaryotes / plant plastids | Present | Host lineage may also retain eukaryotic MVA outside plastids | MEP localized in plastids/chloroplasts derived from cyanobacterial endosymbiosis | Chloroplasts of plants and algae | Presence of MEP in plastids is best explained by bacterial endosymbiosis; this is a central route by which eukaryotes acquired MEP biochemistry (perezgil2024themethylerythritolphosphate pages 7-8, perezgil2024themethylerythritolphosphate pages 1-3) |
| Apicomplexa with plastid-like organelles | Present in plastid/apicoplast-bearing members | Generally MVA absent in the plastid compartment; host-cell pathway status varies by lineage | MEP localized in the apicoplast/plastid-derived organelle | *Plasmodium falciparum* and other plastidial apicomplexans | MEP in these eukaryotes is attributed to retention of plastid-derived metabolism rather than independent invention; distribution is restricted to plastid-bearing lower eukaryotes rather than all protists (perezgil2024themethylerythritolphosphate pages 1-3) |
| Gram-positive cocci with MVA | Usually absent or not dominant | Eukaryotic-like/canonical bacterial MVA occurrence reported | Cytosolic bacterial pathway | Gram-positive cocci noted in pathway surveys | Important exception to the rule that bacteria mainly use MEP; illustrates patchy bacterial acquisition or retention of MVA-type metabolism (garay2026themevalonatepathway pages 16-18, kanno2024archaealmevalonatepathway pages 1-3) |
| Chloroflexota with modified MVA | Usually MEP absent in the reported modified-MVA representatives; some lineages may vary | Modified MVA pathways, including archaeal-type or other derived variants | Cytosolic bacterial pathway | *Candidatus Promineifilum breve* and related Chloroflexota MAGs | Strong recent evidence shows some Chloroflexota bacteria possess archaeal-type MVA genes, likely via horizontal gene transfer; this is a key special case that complicates simple domain-level assignments (kanno2024archaealmevalonatepathway pages 1-3) |
| *Candidatus Promineifilum breve* (special case) | Absent in the reported genome carrying archaeal MVA | Archaeal MVA pathway in a bacterium | Cytosolic bacterial context | *Ca. Promineifilum breve* | A rare, well-supported example of an archaeal MVA pathway in Bacteria; phylogeny suggests HGT-based acquisition and provides direct evidence that archaeal-type MVA is not strictly archaeal in modern distribution (kanno2024archaealmevalonatepathway pages 1-3) |
| Non-model bacterial platforms for biotechnology | Usually MEP if bacterial host is MEP-dominant | Some engineered or naturally unusual hosts may use MVA variants | Depends on host; bacteria generally lack organellar separation | *Pseudomonas putida*, *E. coli* | Comparative biotechnology literature often contrasts bacterial MEP hosts with yeast MVA hosts; recent phylogenetic discussion also argues that ancestral MVA may have had a broader distribution than once assumed, but this remains a higher-level evolutionary interpretation rather than a replacement for observed modern distributions (carruthers2021diversifyingisoprenoidplatforms pages 2-3, carruthers2021diversifyingisoprenoidplatforms pages 13-14) |


*Table: This table summarizes how the MEP and mevalonate pathways are distributed across major domains and lineages, highlighting compartmentation, representative taxa, and important exceptions. It is useful for separating the core bacterial MEP system from neighboring or convergently evolved MVA-based solutions.*

The MEP pathway is found in most bacteria and in plastids of plants and algae (acquired through cyanobacterial endosymbiosis), while the MVA pathway is the primary route in archaea and most eukaryotes (perezgil2024themethylerythritolphosphate pages 7-8, garay2026themevalonatepathway pages 16-18, perezgil2024themethylerythritolphosphate pages 1-3). Animals and fungi use the MVA pathway exclusively. Plants uniquely maintain both complete, nonredundant pathways compartmentalized between plastids (MEP) and cytosol (MVA), and inhibition of one cannot be fully compensated by the other (garay2026themevalonatepathway pages 16-18). Some bacteria, particularly certain Gram-positive cocci, use a eukaryotic-type MVA pathway, and recently the archaeal MVA pathway was documented in the Chloroflexota bacterium *Candidatus* Promineifilum breve, likely acquired via horizontal gene transfer (kanno2024archaealmevalonatepathway pages 1-3).

### 5.2 Evolutionary flexibility and rigidity within the MEP pathway

A landmark comparative genomics survey of 4,400 diverse bacterial species by Marshall et al. (2023) revealed differential evolutionary conservation among MEP enzymes (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 9-10, marshall2023evolutionaryflexibilityand pages 5-7, marshall2023evolutionaryflexibilityand pages 3-5, marshall2023evolutionaryflexibilityand pages 1-2):

- **Dxs is evolutionarily flexible.** The study identified 181 candidate bacterial species that appear to lack Dxs while retaining all other MEP enzymes, suggesting that alternative metabolic routes can bypass this step. Known alternatives include the MTA-isoprenoid shunt (involving RuBisCO-like protein and methylthioxylulose phosphate enzymes), DxrII (a non-homologous Dxr replacement), and suppressor mutations involving AceE, RibB, or YajO overexpression (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 3-5).

- **IspG and IspH are evolutionarily rigid.** No bacterial species were identified that use the MEP pathway without IspG and IspH, and no alternative enzymatic routes could be found to circumvent these Fe-S cluster enzymes. This rigidity has important implications: metabolic engineers seeking to improve terpenoid titers cannot replace IspG/IspH with alternatives but must instead optimize their activity directly (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 5-7, marshall2023evolutionaryflexibilityand pages 1-2).

- **DxrI/II, IspD, IspE, and IspF are also rigid**, retained by essentially all MEP-utilizing species (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 9-10).

### 5.3 Deep evolutionary origin

The MEP pathway evolved prior to the Great Oxygenation Event, and its Fe-S cluster enzymes are considered among the most ancient protein folds (perezgil2024themethylerythritolphosphate pages 7-8, perezgil2024themethylerythritolphosphate pages 1-3). The pathway is considered vertically inherited from a bacterial common ancestor, while MVA pathways show a more complex history involving multiple horizontal gene transfer events (kanno2024archaealmevalonatepathway pages 1-3). An emerging view suggests that an ancestral MVA pathway may have been present in all domains of life, with some lineages losing it after acquiring the MEP pathway (carruthers2021diversifyingisoprenoidplatforms pages 2-3).

## 6. Constraints, Dependencies, and Failure Modes

### 6.1 Ordered dependencies

The seven core MEP steps must proceed sequentially; each substrate is the product of the preceding reaction. There is no known shortcut from MEP directly to HMBPP or from DXP directly to MEcPP (allamand2023themultifacetedmep pages 1-3, rinaldi2022alternativemetabolicpathways pages 4-4).

### 6.2 Cofactor and redox constraints

The pathway requires ThDP (Step 1), NADPH (Step 2), CTP (Step 3), ATP (Step 4), and reducing equivalents delivered to [4Fe-4S] clusters via flavodoxin/ferredoxin systems (Steps 6–7). The dependence of IspG and IspH on iron-sulfur cluster biogenesis and ongoing electron supply makes these steps particularly vulnerable to iron limitation, oxidative stress, and disruption of Fe-S cluster assembly pathways (perezgil2024themethylerythritolphosphate pages 4-4, perezgil2024themethylerythritolphosphate pages 3-4).

### 6.3 Metabolic bottlenecks

Systematic overexpression studies in *Z. mobilis* demonstrated that DXS is the first enzymatic bottleneck; upon DXS overexpression, IspG and IspH become the primary pathway constraints, with massive MEcPP accumulation (khana2023systematicanalysisof pages 2-4). Combined overexpression of DXS, IspG, and IspH mitigated the MEcPP bottleneck and mobilized carbon to downstream products (khana2023systematicanalysisof pages 2-4).

### 6.4 Substrate competition at the prenyl transferase level

IspA, IspB, and UppS compete for common IPP and FPP pools. Knockdown of IspB (octaprenyl diphosphate synthase) can accumulate FPP and redirect flux toward desired terpenoid products, while knockdown of UppS (undecaprenyl diphosphate synthase) is lethal because Und-P is essential for peptidoglycan biosynthesis (kay2024engineeringescherichiacoli pages 2-4, kay2024engineeringescherichiacoli pages 1-2).

### 6.5 Oxidative stress as a pathway failure mode

Oxidative stress conditions impair IspG and IspH activity through damage to their Fe-S clusters, leading to MEcPP accumulation. This has been proposed as an evolved sense-and-response mechanism: MEcPP accumulation signals oxidative stress and may itself function as an antioxidant or signaling molecule, although this remains under active investigation (perezgil2024themethylerythritolphosphate pages 4-4, perezgil2024themethylerythritolphosphate pages 7-8, perezgil2024themethylerythritolphosphate pages 1-3, perezgil2024themethylerythritolphosphate pages 6-7).

## 7. Controversies and Open Questions

**Is MEcPP a bona fide signaling molecule?** Perez-Gil et al. (2024) present compelling evidence that MEcPP accumulates under oxidative stress and influences downstream gene expression, but whether it acts directly as a signaling molecule, as an antioxidant, or both remains debated. Classical antioxidant mechanisms for MEcPP are described as "controversial," and the precise signal transduction mechanism is unknown (perezgil2024themethylerythritolphosphate pages 8-9, perezgil2024themethylerythritolphosphate pages 6-7).

**What are the natural Dxs alternatives?** Marshall et al. (2023) identified 181 candidate species apparently lacking Dxs, but only 2–3% of these possessed the known MTA-isoprenoid shunt enzymes. Whether the remaining species use undiscovered Dxs replacements, harbor Dxs homologs divergent enough to escape detection, or have incomplete genome assemblies remains unclear (marshall2023evolutionaryflexibilityand pages 3-5).

**Why are IspG and IspH evolutionarily indispensable?** Whether the absolute conservation of IspG and IspH reflects an intrinsic chemical constraint (no alternative chemistry can accomplish this transformation) or simply insufficient evolutionary time/opportunity for alternatives to arise is an open question (marshall2023evolutionaryflexibilityand pages 7-9, marshall2023evolutionaryflexibilityand pages 9-10).

**Feedback regulation of the MEP pathway.** The precise feedback mechanisms controlling MEP pathway flux in bacteria remain incompletely characterized. While IPP/DMAPP feedback on DXS has been proposed, and MEcPP levels appear to be regulated through interactions between upstream metabolites (MEP) and downstream prenyl diphosphates, the molecular details of these regulatory circuits are not fully resolved (perezgil2024themethylerythritolphosphate pages 6-7).

**Horizontal gene transfer and pathway mosaicism.** The discovery of archaeal MVA pathways in Chloroflexota bacteria (kanno2024archaealmevalonatepathway pages 1-3) and eukaryotic-type MVA in Gram-positive cocci challenges simple domain-level assignments of biosynthetic pathways. The extent to which horizontal gene transfer has reshuffled isoprenoid pathway components across the tree of life remains an active area of investigation.

**P. putida as a terpenoid production platform.** *Pseudomonas putida* KT2440 is recognized as a prime candidate for isoprenoid bioproduction due to its natural solvent tolerance, broad substrate range for lignocellulosic biomass conversion, and robust native MEP pathway (carruthers2021diversifyingisoprenoidplatforms pages 13-14). However, detailed characterization of MEP pathway regulation and bottlenecks specifically in *P. putida*—as opposed to extrapolation from *E. coli* or *Z. mobilis*—remains limited.

## 8. Key References

1. Allamand, A. et al. (2023). The Multifaceted MEP Pathway: Towards New Therapeutic Perspectives. *Molecules*, 28, 1403. DOI: 10.3390/molecules28031403
2. Marshall, B. et al. (2023). Evolutionary flexibility and rigidity in the bacterial methylerythritol phosphate (MEP) pathway. *Frontiers in Microbiology*, 14. DOI: 10.3389/fmicb.2023.1286626
3. Perez-Gil, J. et al. (2024). The methylerythritol phosphate pathway as an oxidative stress sense and response system. *Nature Communications*, 15. DOI: 10.1038/s41467-024-49483-8
4. Khana, D. B. et al. (2023). Systematic Analysis of Metabolic Bottlenecks in the Methylerythritol 4-Phosphate (MEP) Pathway of *Zymomonas mobilis*. *mSystems*, 8. DOI: 10.1128/msystems.00092-23
5. Rinaldi, M. A. et al. (2022). Alternative metabolic pathways and strategies to high-titre terpenoid production in *Escherichia coli*. *Natural Product Reports*, 39, 90–118. DOI: 10.1039/d1np00025j
6. Kanno, K. et al. (2024). Archaeal mevalonate pathway in the uncultured bacterium *Candidatus* Promineifilum breve belonging to the phylum Chloroflexota. *Applied and Environmental Microbiology*, 90. DOI: 10.1128/aem.01106-24
7. Kay, E. J. et al. (2024). Engineering *Escherichia coli* for increased Und-P availability leads to material improvements in glycan expression technology. *Microbial Cell Factories*, 23. DOI: 10.1186/s12934-024-02339-8
8. Carruthers, D. N. & Lee, T. S. (2021). Diversifying Isoprenoid Platforms via Atypical Carbon Substrates and Non-model Microorganisms. *Frontiers in Microbiology*, 12. DOI: 10.3389/fmicb.2021.791089
9. Hamid, R. (2024). Investigating structural insights and inhibitor strategies in MEP pathway enzymes. Universität des Saarlandes. DOI: 10.22028/d291-41706
10. Garay, A. V. et al. (2026). The Mevalonate Pathway: Characteristics, Innovations, Applications, and Challenges in Biotechnology. DOI: 10.20944/preprints202605.0182.v1

References

1. (allamand2023themultifacetedmep pages 1-3): Alizée Allamand, Teresa Piechowiak, Didier Lièvremont, Michel Rohmer, and Catherine Grosdemange-Billiard. The multifaceted mep pathway: towards new therapeutic perspectives. Molecules, 28:1403, Feb 2023. URL: https://doi.org/10.3390/molecules28031403, doi:10.3390/molecules28031403. This article has 32 citations.

2. (rinaldi2022alternativemetabolicpathways pages 4-4): Mauro A. Rinaldi, Clara A. Ferraz, and Nigel S. Scrutton. Alternative metabolic pathways and strategies to high-titre terpenoid production in<i>escherichia coli</i>. Natural Product Reports, 39:90-118, Jan 2022. URL: https://doi.org/10.1039/d1np00025j, doi:10.1039/d1np00025j. This article has 135 citations and is from a peer-reviewed journal.

3. (kay2024engineeringescherichiacoli pages 2-4): Emily J. Kay, Manoj K. Dooda, Joseph C. Bryant, Amanda J. Reid, Brendan W. Wren, Jerry M. Troutman, and Matthew A. Jorgenson. Engineering escherichia coli for increased und-p availability leads to material improvements in glycan expression technology. Microbial Cell Factories, Mar 2024. URL: https://doi.org/10.1186/s12934-024-02339-8, doi:10.1186/s12934-024-02339-8. This article has 7 citations and is from a peer-reviewed journal.

4. (kay2024engineeringescherichiacoli pages 1-2): Emily J. Kay, Manoj K. Dooda, Joseph C. Bryant, Amanda J. Reid, Brendan W. Wren, Jerry M. Troutman, and Matthew A. Jorgenson. Engineering escherichia coli for increased und-p availability leads to material improvements in glycan expression technology. Microbial Cell Factories, Mar 2024. URL: https://doi.org/10.1186/s12934-024-02339-8, doi:10.1186/s12934-024-02339-8. This article has 7 citations and is from a peer-reviewed journal.

5. (perezgil2024themethylerythritolphosphate pages 7-8): Jordi Perez-Gil, James Behrendorff, Andrew Douw, and Claudia E. Vickers. The methylerythritol phosphate pathway as an oxidative stress sense and response system. Nature Communications, Jun 2024. URL: https://doi.org/10.1038/s41467-024-49483-8, doi:10.1038/s41467-024-49483-8. This article has 74 citations and is from a highest quality peer-reviewed journal.

6. (garay2026themevalonatepathway pages 16-18): Aisel Valle Garay, Cíntia Marques Coelho, Napoleão Fonseca Valadares, Leonardo Ferreira da Silva, Letícia Sousa Cabral, Matheus Castro Leitão, Luiza Cesca Piva, Janice Lisboa De Marco, Brenda Rabello de Camargo, Amanda Araújo Souza, Izadora Cristina Moreira de Oliveira, Matheus Ferroni Schwartz, Túlio Marcos Godoy de Andrade, Talita Souza Carmo, João Ricardo Moreira de Almeida, Fernando Araripe Gonçalves Torres, and Sonia Maria de Freitas. The mevalonate pathway: characteristics, innovations, applications, and challenges in biotechnology. Unknown journal, May 2026. URL: https://doi.org/10.20944/preprints202605.0182.v1, doi:10.20944/preprints202605.0182.v1.

7. (perezgil2024themethylerythritolphosphate pages 1-3): Jordi Perez-Gil, James Behrendorff, Andrew Douw, and Claudia E. Vickers. The methylerythritol phosphate pathway as an oxidative stress sense and response system. Nature Communications, Jun 2024. URL: https://doi.org/10.1038/s41467-024-49483-8, doi:10.1038/s41467-024-49483-8. This article has 74 citations and is from a highest quality peer-reviewed journal.

8. (perezgil2024themethylerythritolphosphate pages 4-4): Jordi Perez-Gil, James Behrendorff, Andrew Douw, and Claudia E. Vickers. The methylerythritol phosphate pathway as an oxidative stress sense and response system. Nature Communications, Jun 2024. URL: https://doi.org/10.1038/s41467-024-49483-8, doi:10.1038/s41467-024-49483-8. This article has 74 citations and is from a highest quality peer-reviewed journal.

9. (marshall2023evolutionaryflexibilityand pages 7-9): Bailey Marshall, Kaustubh Amritkar, Michael Wolfe, Betül Kaçar, and Robert Landick. Evolutionary flexibility and rigidity in the bacterial methylerythritol phosphate (mep) pathway. Frontiers in Microbiology, Nov 2023. URL: https://doi.org/10.3389/fmicb.2023.1286626, doi:10.3389/fmicb.2023.1286626. This article has 21 citations and is from a peer-reviewed journal.

10. (marshall2023evolutionaryflexibilityand pages 9-10): Bailey Marshall, Kaustubh Amritkar, Michael Wolfe, Betül Kaçar, and Robert Landick. Evolutionary flexibility and rigidity in the bacterial methylerythritol phosphate (mep) pathway. Frontiers in Microbiology, Nov 2023. URL: https://doi.org/10.3389/fmicb.2023.1286626, doi:10.3389/fmicb.2023.1286626. This article has 21 citations and is from a peer-reviewed journal.

11. (marshall2023evolutionaryflexibilityand pages 1-2): Bailey Marshall, Kaustubh Amritkar, Michael Wolfe, Betül Kaçar, and Robert Landick. Evolutionary flexibility and rigidity in the bacterial methylerythritol phosphate (mep) pathway. Frontiers in Microbiology, Nov 2023. URL: https://doi.org/10.3389/fmicb.2023.1286626, doi:10.3389/fmicb.2023.1286626. This article has 21 citations and is from a peer-reviewed journal.

12. (hamid2024investigatingstructuralinsights pages 26-31): Rawia Hamid. Investigating structural insights and inhibitor strategies in mep pathway enzymes. Mar 2024. URL: https://doi.org/10.22028/d291-41706, doi:10.22028/d291-41706. This article has 0 citations.

13. (hamid2024investigatingstructuralinsights pages 23-26): Rawia Hamid. Investigating structural insights and inhibitor strategies in mep pathway enzymes. Mar 2024. URL: https://doi.org/10.22028/d291-41706, doi:10.22028/d291-41706. This article has 0 citations.

14. (marshall2023evolutionaryflexibilityand pages 3-5): Bailey Marshall, Kaustubh Amritkar, Michael Wolfe, Betül Kaçar, and Robert Landick. Evolutionary flexibility and rigidity in the bacterial methylerythritol phosphate (mep) pathway. Frontiers in Microbiology, Nov 2023. URL: https://doi.org/10.3389/fmicb.2023.1286626, doi:10.3389/fmicb.2023.1286626. This article has 21 citations and is from a peer-reviewed journal.

15. (marshall2023evolutionaryflexibilityand pages 5-7): Bailey Marshall, Kaustubh Amritkar, Michael Wolfe, Betül Kaçar, and Robert Landick. Evolutionary flexibility and rigidity in the bacterial methylerythritol phosphate (mep) pathway. Frontiers in Microbiology, Nov 2023. URL: https://doi.org/10.3389/fmicb.2023.1286626, doi:10.3389/fmicb.2023.1286626. This article has 21 citations and is from a peer-reviewed journal.

16. (khana2023systematicanalysisof pages 2-4): Daven B. Khana, Mehmet Tatli, Julio Rivera Vazquez, Sarathi M. Weraduwage, Noah Stern, Alexander S. Hebert, Edna Angelica Trujillo, David M. Stevenson, Joshua J. Coon, Thomas D. Sharky, and Daniel Amador-Noguez. Systematic analysis of metabolic bottlenecks in the methylerythritol 4-phosphate (mep) pathway of zymomonas mobilis. mSystems, Apr 2023. URL: https://doi.org/10.1128/msystems.00092-23, doi:10.1128/msystems.00092-23. This article has 18 citations and is from a peer-reviewed journal.

17. (perezgil2024themethylerythritolphosphate pages 6-7): Jordi Perez-Gil, James Behrendorff, Andrew Douw, and Claudia E. Vickers. The methylerythritol phosphate pathway as an oxidative stress sense and response system. Nature Communications, Jun 2024. URL: https://doi.org/10.1038/s41467-024-49483-8, doi:10.1038/s41467-024-49483-8. This article has 74 citations and is from a highest quality peer-reviewed journal.

18. (perezgil2024themethylerythritolphosphate pages 4-6): Jordi Perez-Gil, James Behrendorff, Andrew Douw, and Claudia E. Vickers. The methylerythritol phosphate pathway as an oxidative stress sense and response system. Nature Communications, Jun 2024. URL: https://doi.org/10.1038/s41467-024-49483-8, doi:10.1038/s41467-024-49483-8. This article has 74 citations and is from a highest quality peer-reviewed journal.

19. (perezgil2024themethylerythritolphosphate pages 8-9): Jordi Perez-Gil, James Behrendorff, Andrew Douw, and Claudia E. Vickers. The methylerythritol phosphate pathway as an oxidative stress sense and response system. Nature Communications, Jun 2024. URL: https://doi.org/10.1038/s41467-024-49483-8, doi:10.1038/s41467-024-49483-8. This article has 74 citations and is from a highest quality peer-reviewed journal.

20. (bao2021adynamicand pages 3-4): Shao-Heng Bao, Hui Jiang, Ling-Yun Zhu, Ge Yao, Peng-Gang Han, Xiu-Kun Wan, Kang Wang, Tian-Yu Song, Chang-Jun Liu, Shan Wang, Zhe-Yang Zhang, Dong-Yi Zhang, and Er Meng. A dynamic and multilocus metabolic regulation strategy using quorum-sensing-controlled bacterial small rna. Cell reports, 36 3:109413, Jul 2021. URL: https://doi.org/10.1016/j.celrep.2021.109413, doi:10.1016/j.celrep.2021.109413. This article has 22 citations and is from a highest quality peer-reviewed journal.

21. (perezgil2024themethylerythritolphosphate pages 3-4): Jordi Perez-Gil, James Behrendorff, Andrew Douw, and Claudia E. Vickers. The methylerythritol phosphate pathway as an oxidative stress sense and response system. Nature Communications, Jun 2024. URL: https://doi.org/10.1038/s41467-024-49483-8, doi:10.1038/s41467-024-49483-8. This article has 74 citations and is from a highest quality peer-reviewed journal.

22. (kanno2024archaealmevalonatepathway pages 1-3): Kosuke Kanno, Riko Kuriki, Yoko Yasuno, Tetsuro Shinada, Tomokazu Ito, and Hisashi Hemmi. Archaeal mevalonate pathway in the uncultured bacterium <i>candidatus</i> promineifilum breve belonging to the phylum chloroflexota. Applied and Environmental Microbiology, Aug 2024. URL: https://doi.org/10.1128/aem.01106-24, doi:10.1128/aem.01106-24. This article has 6 citations and is from a peer-reviewed journal.

23. (carruthers2021diversifyingisoprenoidplatforms pages 2-3): David N. Carruthers and Taek Soon Lee. Diversifying isoprenoid platforms via atypical carbon substrates and non-model microorganisms. Frontiers in Microbiology, Dec 2021. URL: https://doi.org/10.3389/fmicb.2021.791089, doi:10.3389/fmicb.2021.791089. This article has 19 citations and is from a peer-reviewed journal.

24. (carruthers2021diversifyingisoprenoidplatforms pages 13-14): David N. Carruthers and Taek Soon Lee. Diversifying isoprenoid platforms via atypical carbon substrates and non-model microorganisms. Frontiers in Microbiology, Dec 2021. URL: https://doi.org/10.3389/fmicb.2021.791089, doi:10.3389/fmicb.2021.791089. This article has 19 citations and is from a peer-reviewed journal.

## Artifacts

- [Edison artifact artifact-00](terpenoid_backbone_biosynthesis-deep-research-falcon_artifacts/artifact-00.md)
- [Edison artifact artifact-01](terpenoid_backbone_biosynthesis-deep-research-falcon_artifacts/artifact-01.md)

## Citations

1. rinaldi2022alternativemetabolicpathways pages 4-4
2. khana2023systematicanalysisof pages 2-4
3. kay2024engineeringescherichiacoli pages 2-4
4. kay2024engineeringescherichiacoli pages 1-2
5. perezgil2024themethylerythritolphosphate pages 4-6
6. perezgil2024themethylerythritolphosphate pages 8-9
7. garay2026themevalonatepathway pages 16-18
8. perezgil2024themethylerythritolphosphate pages 1-3
9. kanno2024archaealmevalonatepathway pages 1-3
10. carruthers2021diversifyingisoprenoidplatforms pages 2-3
11. marshall2023evolutionaryflexibilityand pages 3-5
12. perezgil2024themethylerythritolphosphate pages 6-7
13. carruthers2021diversifyingisoprenoidplatforms pages 13-14
14. allamand2023themultifacetedmep pages 1-3
15. perezgil2024themethylerythritolphosphate pages 7-8
16. perezgil2024themethylerythritolphosphate pages 4-4
17. marshall2023evolutionaryflexibilityand pages 7-9
18. marshall2023evolutionaryflexibilityand pages 9-10
19. marshall2023evolutionaryflexibilityand pages 1-2
20. hamid2024investigatingstructuralinsights pages 26-31
21. hamid2024investigatingstructuralinsights pages 23-26
22. marshall2023evolutionaryflexibilityand pages 5-7
23. bao2021adynamicand pages 3-4
24. perezgil2024themethylerythritolphosphate pages 3-4
25. (2E,6E)-farnesyl-diphosphate specific
26. 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol 2-phosphate
27. 4Fe-4S
28. https://doi.org/10.3390/molecules28031403,
29. https://doi.org/10.1039/d1np00025j,
30. https://doi.org/10.1186/s12934-024-02339-8,
31. https://doi.org/10.1038/s41467-024-49483-8,
32. https://doi.org/10.20944/preprints202605.0182.v1,
33. https://doi.org/10.3389/fmicb.2023.1286626,
34. https://doi.org/10.22028/d291-41706,
35. https://doi.org/10.1128/msystems.00092-23,
36. https://doi.org/10.1016/j.celrep.2021.109413,
37. https://doi.org/10.1128/aem.01106-24,
38. https://doi.org/10.3389/fmicb.2021.791089,